The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.

Saved in:
Bibliographic Details
Title: The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
Authors: Miao B; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, University of Heidelberg, Heidelberg, Germany., Bauer AS; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany., Hufnagel K; Infections and Cancer Epidemiology (F022), German Cancer Research Center (DKFZ), Heidelberg, Germany., Wu Y; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany., Trajkovic-Arsic M; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Pirona AC; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany., Giese N; Research Laboratory of the European Pancreas Centre (EPZ) Integrative Oncology Group, University Clinic Heidelberg, Heidelberg, Germany., Taipale J; Division of Functional Genomics, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden., Siveke JT; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hoheisel JD; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany., Lueong S; Division of Functional Genome Analysis (B070), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK, partner site Essen) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: International journal of cancer [Int J Cancer] 2020 Jul 01; Vol. 147 (1), pp. 189-201. Date of Electronic Publication: 2020 Jan 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0215
DOI:10.1002/ijc.32831